(Updated - February 4, 2022 5:31 AM EST)

Cowen analyst Boris Peaker upgraded Jounce Therapeutics (NASDAQ: JNCE) from Market ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE